cp wire

CP Wire Articles

  • The agreement will lower out-of-pocket costs for patients
  • It will cover Brilinta prescriptions
  • Clinical outcomes will determine the level of shared costs between AstraZeneca... read more
Mon, 01/28/19 - 12:06 pm

MorphoSys AG (FSE: MOR; Prime Standard Segment, MDAX & TecDAX; NASDAQ: MOR) announced on 1/26/19 that it was informed that in its lawsuit against Janssen Biotech and Genmab A/S, the United... read more

Mon, 01/28/19 - 10:10 am

Tuesday

This was a short work week for many due to MLK Day on Monday, but Tuesday started off Q4 earnings... read more
Sun, 01/27/19 - 07:07 pm
  • Coherus’ license period in the U.S. commences on December 15, 2023
  • Coherus will pay royalties to AbbVie
  • The company has six candidates in development

Coherus... read more

Fri, 01/25/19 - 10:41 am
  • ArQule is eligible to receive up to $326 million in regulatory and commercial milestone payments related to the BAL087 license agreement
  • BAL087 has U.S. and EU orphan drug... read more
Thu, 01/24/19 - 10:38 am

Pages